Login / Signup

Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity.

Szilvia BarsiHenrietta PappAlberto ValdeolivasDániel J. TóthAnett KuczmogMónika MadaiLászló HunyadyPéter VárnaiJulio Saez-RodriguezFerenc JakabBence Szalai
Published in: PLoS Comput. Biol. (2022)
Keyphrases
  • drug discovery
  • clinical trials
  • drug design
  • pharmaceutical industry
  • information systems
  • data sets
  • neural network
  • data mining
  • high density
  • activity patterns
  • virtual screening